Skip to main content
. 2008 Oct 27;6:62. doi: 10.1186/1479-5876-6-62

Table 2.

Recent evidence for indirect immunomodulatory mechanisms of HDI

Increase in Tumor Infiltrating cells36
Development of autoantibodies and clinical manifestations of autoimmunity (~30%)37,38
Decrease in Circulating Treg cells51
Modulation of the STAT1/STAT3 balance in tumor cells and host lymphocytes52
Change in serum cytokine concentrations53
Normalization of T cell STAT 1 signaling defects in peripheral blood lymphocytes54